Janux Therapeutics, Inc. · NASDAQ:JANX
State Street Corp's stake in Janux Therapeutics, Inc. fell to 4.10% (Schedule 13G)
Event Mar 31, 2026 · Filed May 12, 2026
State Street Corp's stake in Janux Therapeutics, Inc. fell to 4.10%, 2,464,017 shares, as a passive investor on Mar 31, 2026. Filed May 12, 2026 (Schedule 13G).
- Stake
- 4.10%
- Shares
- 2,464,017
- Intent
- Passive
- What changed
- Fell below 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| STATE STREET CORPORATION | 4.10% | 2,464,017 |
Source
Related
- Janux Therapeutics, Inc.
- State Street Corp
- Janux Therapeutics, Inc. shareholders
- Schedule 13G · State Street Corp · Feb 9, 2026
- Schedule 13G/A · Point72 Asset Management, L.P. · Aug 14, 2026
- Schedule 13G/A · Janus Henderson Group PLC · Aug 13, 2026
- Form 4 · Campbell David Alan · Jul 31, 2026
- Schedule 13G/A · BlackRock, Inc. · Jul 28, 2026
- Form 4 · Campbell David Alan · Jul 10, 2026